温馨提示:本站仅提供公开网络链接索引服务,不存储、不篡改任何第三方内容,所有内容版权归原作者所有
AI智能索引来源:http://www.msd.com/patients
点击访问原文链接

Patients - MSD

CompanyWho we areWhat we doStoriesHistorySustainabilitySustainability overviewPhilanthropyMSD Medical Outreach ProgramImpact Venture FundTransparency disclosuresSustainability resourcesLeadershipLeadership overviewBoard of directorsExecutive teamCulture & valuesCulture & values overviewCode of conduct, ethics and complianceDiversity and inclusionPolicies and positionsSuppliersSuppliers overviewSupplier registrationSupplier help for AribaResearchResearch overviewOncologyVaccinesInfectious diseasesCardiometabolic and respiratory diseasesImmunologyNeuroscienceOphthalmologyAreas of innovationData science and artificial intelligenceGreen and sustainable scienceOur therapeutic modalitiesTranslational medicinePipelineBusiness development and licensingClinical TrialsClinical trials overviewDiversity in clinical trialsR&D locationsHow we inventMeet our scientistsPublicationsSafety data sheets (SDS)Product patentsPatientsPatients overviewPlay an active role in your health careFighting counterfeit medicineMediaMedia overviewNews releasesCompany statementsCompany fact sheetInvestorsInvestors overviewEvents and presentationsStock informationCareersLearn moreContact usPlay an active role in your health careLearn moreSee contactsThis red chair is a reminder that patients can’t wait Colleagues rally around a red chair as a reminder to work urgently for the people who need lifesaving medicines and vaccinesMore treatment options mean more flexibility for people with cancer Additional treatment options can help patients make time for their health and their prioritiesPodcast: A candid conversation about diversity in clinical trials  Hear a patient and a doctor share why they want more people involved in medical studiesPodcast: How to bridge diversity gaps in cancer clinical trials Luther Clark talks with Lazarex Cancer Foundation's Dana Dornsife and Marya Shegog about increasing access among historically underrepresented communitiesWho we are We aspire to be the premier research-intensive biopharmaceutical company.Research We believe research is the will to conquer the impossible and that science will lead the way.Our history For 130 years, we’ve been guided by the view that great medicines and vaccines can change the world.MSD ManualsClinical trialsImpact ReportMSD for MothersMSD Animal HealthContact UsForward-looking statementCookie policyPrivacyTerms of useAccessibilitySitemapwww.sec.govDecline

智能索引记录